Evidence map›Paper›PMID 40745380›Full record

ArticleScientific reports2025

Graph theoretic and machine learning approaches in molecular property prediction of bladder cancer therapeutics.

Huiling Qin, Atef F Hashem, Muhammad Farhan Hanif, Osman Abubakar Fiidow

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Huiling QinDepartment of Rehabilitation, The Affiliated Hospital of Youjiang Medical University for Nationalities, Baise, China.
Atef F HashemDepartment of Mathematics and Statistics, College of Science, Imam Mohammad Ibn Saud Islamic University (IMSIU), Riyadh, 11432, Saudi Arabia.
Muhammad Farhan HanifDepartment of Mathematics and Statistics, The University of Lahore, Lahore Campus, Pakistan.
Osman Abubakar FiidowDepartment of Public Health, Faculty of Health Science, Salaam University, Mogadishu, Somalia. osmanfiidow@salaam.edu.so.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This work introduces a hybrid computational approach in which degree-based topological descriptors are harnessed with the aid of advanced regression models and artificial neural networks (ANNs) to predict the crucial physicochemical properties of 17 drugs for the treatment of bladder cancer. Each molecule is assigned a molecular graph, from which a series of topological descriptors such as Zagreb indices, Randic index, Atom Bond Connectivity (ABC), and Symmetric Division Degree (SSD)are computed. These indices are used as input features by various regression models along with linear, cubic, and feedforward ANNs. The performance of the models is analyzed using metrics such as Mean Squared Error (MSE), Root Mean Squared Error (RMSE), Mean Absolute Error (MAE), and the coefficient of determination [Formula: see text]. ANNs showed the best predictive performance with the [Formula: see text] value achieving 0.99. Moreover, SHAP (SHapley Additive exPlanations) analysis was used to explain the contribution of each descriptor toward the models' predictions. The findings validate the promise of the combination of graph-theoretic descriptors with the tools of machine learning to achieve solid and interpretable models of molecular property prediction, which hold the potential for drug discovery and optimization in oncologic applications.

Indexed as

Antineoplastic AgentsMachine LearningUrinary Bladder NeoplasmsHumansNeural Networks, ComputerAntineoplastic AgentsArtificial Neural Networks (ANN)Bladder Cancer DrugsCubic RegressionDegree-Based DescriptorsLinear RegressionMolecular GraphsQSPRSHAP AnalysisTopological Indices

Identifiers

PMID40745380
PMCPMC12313902

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.